Eskayef Pharmaceuticals Ltd.

Eskayef Pharmaceuticals Ltd. is one of the leaders in Bangladesh’s pharmaceutical industry. With its presence across the world, it has earned coveted accreditations from the US FDA, UK MHRA, EU EMA, TGA Australia, and more. Eskayef spread its wings in 1990 when the Bangladeshi operations of SmithKline & French were acquired by Transcom Group. Eskayef prides itself on being a trusted manufacturer of top-quality medicine for Bangladesh and the world.

Incepta Pharmaceuticals Ltd.

Incepta Pharmaceuticals Ltd. is a leading pharmaceutical company in Bangladesh established in the year 1999. The company has a very big manufacturing facility located at Savar and Dhamrai, 35 and 53 kilometer away respectively from the center of the capital city Dhaka. The company produces various types of dosage forms which include tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, nasal sprays, eye drops, creams, ointments, lotions, gels, prefilled syringes, liquid filled hard gelatin capsules, lyophilized injections, human vaccine etc. Since its inception, Incepta has been launching new and innovative products in order to fulfill unmet demand of the medical community. The focus has been to bring more new technologically advanced molecules to this country. The company specializes in value added high technology dosage forms like sustained release tablets, quick mouth dissolving tablets, effervescent tablets, barrier coated delayed release tablets, prefilled syringe products, Insulin and Insulin analogue and biological products, among others . It has established a modern research and development laboratory for the development of new, advanced dosage forms for various drugs and devices like poorly soluble drugs, dry powder inhalers, coated pellets, modified release products, taste masked preparation etc. Incepta has a very competent sales team, which promotes the specialties throughout the country. The company virtually covers every single corner of the rural as well as urban area of Bangladesh. It has its own large distribution network having 23 depots all over the country. The company has a clear vision to become a leading research based dosage form manufacturing company with global presence within a short period of time. With this view in mind the company started to expand its business in overseas markets. Currently Incepta exports to 68 different countries around the world.

Opsonin Pharma Ltd

Opsonin Pharma Ltd. (OPL) develops, manufactures and markets generic medicines for human use. Our value-added products improve the quality of life of people In Bangladesh as well as abroad and help them enjoy longer, healthier, and more productive lives. OPL has been known for long as a provider of quality medicines at affordable prices. Opsonin has for long been established and recognized as one of the leading, progressive and modern pharmaceutical companies in the country. Opsonin is committed to contribute to the national healthcare sector to a great extent and strengthen its global presence. Modern sophisticated machineries and highly qualified and skilled professionals in all concerned departments at Opsonin Pharma Ltd. have made Opsonin unique in the pharmaceutical sector. Opsonin Pharma Ltd is committed to improve its position continuously as a Leading Pharmaceutical company in Bangladesh and strengthen its global presence. The company is now manufacturing 276 brands with 661 SKUs as Pharmaceutical finished products. We also manufacturing animal health products & consumer products under Agrovet Unit & Opsonin Consumer limited respectively.

unimed unihealth group

UniMed UniHealth began its journey in the year 1997 in Bangladesh by introducing life-saving and innovative pharmaceutical products from world class pharmaceutical companies like Grunenthal, Biotest, Abbott, Janssen and Vifor. A team of dedicated professionals having experience in multinational and leading local pharmaceutical companies under the leadership of Mr M Mosaddek Hossain prepared the plan, determined the strategies and progressed to develop the organization. Within a short period of time, the organization could successfully introduce a number of new chemical entities (NCEs) providing improved benefits to the patients. The development of manufacturing capabilities in the year 2000 allowed introduction of a large number of branded generics in a number of specialty therapeutic areas. UniMed UniHealth ensured highest quality products from the beginning through procurement of active ingredients and excipients from selected and controlled sources, systematically processing in well designed and equipped facilities in compliance to regulatory requirements maintaining cGMP, GLP and ISO standards. UniMed UniHealth organized professional marketing with focused promotion through dedicated well trained teams and supplied the products throughout the country with its own developed distribution network. UniMed UniHealth believes and adheres to values like Quality, Knowledge and Responsibility in all aspects of its operation and earned respect and recognition of its valued customers in the healthcare sector of Bangladesh.

Mensa Group

The group of companies that is today known as MENSA GROUP started through the establishment of PT Menjangan Sakti by its founder – Mr. Jimmy Sudharta in April 1975. The company started its business by trading pharmaceutical raw materials throughout Indonesia. With time the company expanded its business and diversified its activity to include the cosmetic, food and feed industries. Continuous growth of PT Menjangan Sakti has provided the company the ability and resources to expand into related business. Starting 1981, PT Menjangan Sakti acquired several other companies in related activity including pharmaceutical manufacturing companies and Distribution Company, forming what is today known as Mensa Group. Mensa Group comprises of several companies with diversified activity such as: - importing and trading pharmaceutical raw materials including food, feed and cosmetics; - pharmaceutical manufacturing ; - medical supplies and dental equipment manufacturing; - Pharmaceutical, hospital / medical supplies and consumer goods distribution. The group employs approximately 5000 employees, and main aim in the near future is to establish a solid synergy between the companies and amongst other to develop a nationwide distribution network as an asset for further growth.